Data presented at the European Society of Cardiology (ESC) congress suggest that widespread implementation of primary percutaneous coronary intervention (PCI) across Europe did not correlate with a reduction in mortality rates following heart attacks, according to Medical Xpress reporting.
Primary PCI, a procedure involving the opening of blocked coronary arteries, has been the preferred immediate treatment for ST-elevation myocardial infarction (STEMI), a severe type of heart attack, for some time. The procedure is considerably more resource-intensive than previous standards of care and necessitates a rapid response from specialized medical teams to achieve optimal outcomes, as detailed in a 2019 study published in the Ulster Medical Journal.
The “Stent for Life” initiative, active in Europe between 2008 and 2016, aimed to improve outcomes for STEMI patients by accelerating access to primary PCI. The initiative focused on reducing the time between a patient experiencing symptoms and receiving reperfusion therapy – restoring blood flow to the heart – and increasing the overall number of patients undergoing the procedure. However, the ESC data indicate that this broad expansion of PCI services did not translate into a corresponding decrease in mortality.
Current European Society of Cardiology guidelines recommend that primary PCI be performed within 120 minutes of electrocardiographic diagnosis when a patient presents in a prehospital setting. This timeframe is reduced to 60 minutes if the diagnosis is made in a hospital equipped to perform primary PCI.
A nationwide registry analysis of primary PCI procedures performed in the United Kingdom between 2005 and 2018, examined trends in treatment and clinical outcomes following the publication of key clinical trials and guideline updates. The study, published in 2019, analyzed data from over 19,000 patients.
The findings raise questions about the effectiveness of simply increasing the volume of PCI procedures without addressing other potential factors influencing heart attack outcomes. Further research is needed to determine the optimal strategies for improving survival rates in STEMI patients.
